Crystal structure of (E)-2-[(2-bromopyridin-3-yl)methylidene]-6-methoxy-3,4-dihydronaphthalen-1(2H)-one and 3-[(E)-(6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-ylidene)methyl]pyridin-2(1H)-one

被引:5
作者
Zingales, Sarah K. [1 ]
Moore, Morgan E. [1 ]
Goetz, Andrew D. [1 ]
Padgett, Clifford W. [1 ]
机构
[1] Armstrong State Univ, 11935 Abercorn St, Savanah, GA 31419 USA
关键词
crystal structure; chalcone; 3-[(E)-(6-Methoxy-3,4-dihydronaphth-2-oylidene)methyl]-1H-pyridin-2-one and (E)-2-[(2-bromo-3-pyridyl)methylidene]-6-methoxy-3,4-dihydronaphthalen-1-one;
D O I
10.1107/S2056989016009300
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The title compounds C17H14BrNO2, (I), and C17H15NO3, (II), were obtained from the reaction of 6-methoxy-3,4-dihydro-2H-naphthalen-1-one and 2-bromonicotinaldehyde in ethanol. Compound (I) was the expected product and compound (II) was the oxidation product from air exposure. In the crystal structure of compound (I), there are no short contacts or hydrogen bonds. The structure does display pi-pi interactions between adjacent benzene rings and adjacent pyridyl rings. Compound (II) contains two independent molecules, A and B, in the asymmetric unit; both are non-planar, the dihedral angles between the methoxybenzene and 1H-pyridin-2-one mean planes being 35.07 (9)degrees in A and 35.28 (9)degrees in B. In each molecule, the 1H-pyridin-2-one unit participates in intermolecular N-H center dot center dot center dot O hydrogen bonding to another molecule of the same type (A to A or B to B). The structure also displays pi-pi interactions between the pyridyl and the benzene rings of non-equivalent molecules (viz., A to B and B to A).
引用
收藏
页码:955 / +
页数:25
相关论文
共 10 条
[1]   Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents [J].
Bandgar, Babasaheb P. ;
Gawande, Shrikant S. ;
Bodade, Ragini G. ;
Totre, Jalinder V. ;
Khobragade, Chandrahas N. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (03) :1364-1370
[2]   Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography [J].
Dimmock, JR ;
Zello, GA ;
Oloo, EO ;
Quail, JW ;
Kraatz, HB ;
Perjési, P ;
Aradi, F ;
Takács-Novák, K ;
Allen, TM ;
Santos, CL ;
Balzarini, J ;
De Clercq, E ;
Stables, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :3103-3111
[3]   The Cambridge Structural Database [J].
Groom, Colin R. ;
Bruno, Ian J. ;
Lightfoot, Matthew P. ;
Ward, Suzanna C. .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2016, 72 :171-179
[4]   Recent progress in therapeutic applications of chalcones [J].
Katsori, Anna-Maria ;
Hadjipavlou-Litina, Dimitra .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (10) :1575-1596
[5]   A review of anti-infective and anti-inflammatory chalcones [J].
Nowakowska, Zdzislawa .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (02) :125-137
[6]   Synthesis and Antimicrobial Activity of Some New Chalcones of 2-Acetyl Pyridine [J].
Prasad, Y. Rajendra ;
Kumar, P. Praveen ;
Kumar, P. Ravi ;
Rao, A. Srinivasa .
E-JOURNAL OF CHEMISTRY, 2008, 5 (01) :144-148
[7]  
Rigaku Corporation, 1998, REQAB
[8]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122
[9]   Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: Structure-activity relationship [J].
Shenvi, Suvarna ;
Kumar, Krishna ;
Hatti, Kaushik S. ;
Rijesh, K. ;
Diwakar, Latha ;
Reddy, G. Chandrasekara .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :435-442
[10]   Novel tetralone-derived retinoic acid metabolism blocking agents: Synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays [J].
Yee, SW ;
Jarno, L ;
Gomaa, MS ;
Elford, C ;
Ooi, LL ;
Coogan, MP ;
McClelland, R ;
Nicholson, RI ;
Evans, BAJ ;
Brancale, A ;
Simons, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7123-7131